About Pudee

Reliability, Responsibility and Rapidity

Founded in 2007, focus on the synthesis of small molecule compounds and the extraction of some natural compounds. We develop, produce and sell high-quality advanced intermediates and some APIs with competitive prices.
Get Appointment

Contact Info

  • Building 2, Handa Science and Technology Park
    No. 8 Pioneer Road
    High-tech Zone. Suzhou.
  • 86 512 6803 2792
    86 512 6803 2791
  • willdyhan@pudeepharm.com
    sales@pudeepharm.com

Product List

Ribociclib intermediate 3
Ribociclib intermediate 3 | 1374639-77-6
" Ribociclib (trade name Kisqali) is an inhibitor of cyclin D1/CDK4 and CDK6, and is used for the treatment of certain kinds of breast cancer. It is……
Ribociclib intermediate 4
Ribociclib intermediate 4 | 1211443-58-1
" Ribociclib (trade name Kisqali) is an inhibitor of cyclin D1/CDK4 and CDK6, and is used for the treatment of certain kinds of breast cancer. It is……
Brigatinib Intermediate 4
Brigatinib Intermediate 4 | 1197953-49-3
" Brigatinib is an investigational small-molecule targeted cancer therapy. It acts as both a anaplastic lymphoma kinase (ALK) and epidermal growth f……
Brigatinib intermediate 1
Brigatinib intermediate 1 | 1089279-91-3
" Brigatinib is an investigational small-molecule targeted cancer therapy. It acts as both a anaplastic lymphoma kinase (ALK) and epidermal growth f……
Brigatinib intermediate 3
Brigatinib intermediate 3 | 761440-75-9
" Brigatinib is an investigational small-molecule targeted cancer therapy. It acts as both a anaplastic lymphoma kinase (ALK) and epidermal growth f……
Brigatinib Intermediate 2
Brigatinib Intermediate 2 | 1089279-90-2
" Brigatinib is an investigational small-molecule targeted cancer therapy. It acts as both a anaplastic lymphoma kinase (ALK) and epidermal growth f……
Brigatinib
Brigatinib | 1197953-54-0
" Brigatinib is an investigational small-molecule targeted cancer therapy. It acts as both a anaplastic lymphoma kinase (ALK) and epidermal growth f……
Abemaciclib
Abemaciclib | 1231929-97-7
" Abemaciclib is a drug for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly. and it acts as a CDK inhibitor se……
Abemaciclib Intermediate 1
Abemaciclib Intermediate 1 | 1231930-42-9
" Abemaciclib is a drug for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly. and it acts as a CDK inhibitor se……